CVE-2018-2739: oracle corporation coreid access
Vulnerability summary
CVE-2018-2739 is a critical (CVSS 9.3) vulnerability in oracle corporation coreid access. EPSS estimates a 2.24% chance of exploitation in the next 30 days, higher than 82.5% of scored vulnerabilities.
Timeline
- 19-04-2018PublishedVulnerability first disclosed.
- 03-10-2024Last modifiedVulnerability information updated.
Description
Vulnerability in the Oracle Access Manager component of Oracle Fusion Middleware (subcomponent: Web Server Plugin). Supported versions that are affected are 10.1.4.3.0, 11.1.2.3.0 and 12.2.1.3.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Access Manager. Successful attacks require human interaction from a person other than the attacker and while the vulnerability is in Oracle Access Manager, attacks may significantly impact additional products. Successful attacks of this vulnerability can result in unauthorized creation, deletion or modification access to critical data or all Oracle Access Manager accessible data as well as unauthorized access to critical data or complete access to all Oracle Access Manager accessible data. CVSS 3.0 Base Score 9.3 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.0/AV:N/AC:L/PR:N/UI:R/S:C/C:H/I:H/A:N).
CVSS metrics
2 scores · 1 source · 2 versionsEPSS trend
Probability
2.24%
Chance of exploitation in the next 30 days
Percentile
83%
Versus all other CVEs
30-day change
-0.04 pp
From 2.28% on 18-09-2026
Known exploited
Compare KEV catalogsNot in any of the 3 tracked catalogs.
Public exploits
0 foundNo public exploits indexed.
Weaknesses
CWE · root causeNo weakness data has been published for this record.
Affected systems
Oracle1 product
- access_manager10.1.4.3.0 | 11.1.2.3.0 | 12.2.1.3.0
Oracle corporation1 product
- coreid access10.1.4.3.0 | 11.1.2.3.0 | 12.2.1.3.0
2 vendors · 2 products
References
3 links- www.oracle.com/technetwork/security-advisory/cpuapr2018-3678067.htmlX Refsource CONFIRMPatchVendor Advisory